D-PHARMA
Timeline
9 events since 2023Filings
Financial
Establishments
2023202420252026
Deadline for the 2026 accounts: 30-04-2027
2026
Annual accounts 2025 filed PDFmicro format · 91 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0804682997
2025
Equity above €150,000 equity €195,050 ▲69.8% With a profit in every financial year since 2023, equity grows to €195,050.
Annual accounts 2024 filed PDFmicro format · 2 days before the deadline
2024
Highest result from 2023 to 2025 net €85,743 ▲222% The operating result of €112,907 and the net result of €85,743 are both a record.
Equity above €100,000 equity €114,838 ▲295% With a profit in every financial year since 2023, equity grows to €114,838.
Annual accounts 2023 filed PDFmicro format · 1 day before the deadline
2023
IncorporationFounding capital of €2,500, 1,000 shares · Founders: and · Appointment: (director) · published on 11-08-20235 points ▸
- Founder,
- Founder,
- Founding capital, €2,500, 1,000 shares
- Board rule, 1
- Director appointment, (director (not named in the articles))
- The deed holds 1 more point.
First establishment Meeslaan 14, Brasschaat
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank